LSD-Like drugs are out of the haze and back in the labs
Even so, Ms. Marcy, who is now free of cancer, says Timothy Leary got it one-third right. “The ‘turn on’ doesn’t have to be emphasized at all,” she said. “The ‘drop out’ is an absolute mistake. But the ‘tune in’ is crucial.” “I tuned in,” she said. “Tuned in to the world, to me, to things I used to love, to my relationships, to my family. ‘Tune in’ is what it’s all about.”
Psychoactive substances, often derived from mushrooms, have been part of human cultures from Central and South America to the Sahara for thousands of years. Essentially, modern scientists are picking up where their forerunners of the ’50s and ’60s left off. They are studying hallucinogens’ potential to help smokers kick the habit, to undo addictions to drugs and alcohol, to cope with cluster headaches and depression, and to deal with obsessive-compulsive and post-traumatic stress disorders. Institutions where such work is underway include New York University; Johns Hopkins University; the University of California, Los Angeles; Psychiatric University Hospital in Zurich; and Imperial College in London.
Original Article (New York Times):
LSD-Like drugs are out of the haze and back in the labs
Artwork Fair Use: Wellcome Images